V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310006935 | 310004133 | 1.67 | 62.1 | Curative (C) | 2016-03-06 | 2016-04-04 | Carboplatin + Liposomal Doxorubicin | N | N | 310014350 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006936 | 310004135 | null | 93.3 | Palliative (P) | 2015-02-04 | 2015-02-09 | CISPLATIN + GEMCITABINE | 2 | N | 310014361 | CISPLATIN + GEMCITABINE |
| 310006937 | 310004136 | null | 13 | Palliative (P) | 2018-04-26 | 2018-05-12 | PEMBROLIZUMAB | N | N | 310014391 | PEMBROLIZUMAB |
| 310006938 | 310004137 | 1.66 | 42 | Curative (C) | 2016-07-13 | 2016-07-14 | BEAM | N | N | 310014414 | BEAM |
| 310006939 | 310004137 | null | 67.3 | Palliative (P) | 2015-01-01 | 2015-01-01 | Carboplatin + Liposomal Doxorubicin | N | N | 310014414 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006940 | 310004137 | 1.55 | null | Palliative (P) | 2014-11-24 | 2014-11-26 | Brentuximab Vedotin | N | N | 310014414 | BRENTUXIMAB |
| 310006942 | 310004141 | 1.72 | 14.8 | Disease modification (D) | 2013-11-14 | 2014-01-01 | GEMCITABINE | Y | null | 310014434 | GEMCITABINE |
| 310006943 | 310004142 | 1.59 | 76 | null | 2013-06-27 | 2013-06-28 | LEAM | 02 | N | 310014449 | LEAM |
| 310006944 | 310004142 | 1.84 | 76.9 | null | 2016-03-27 | 2016-03-27 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 310014449 | GEMCITABINE |
| 310006945 | 310004144 | 1.67 | 53.9 | Palliative (P) | 2015-08-04 | 2015-08-05 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310014474 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006946 | 310004145 | 1.77 | null | Curative (C) | 2016-10-26 | 2016-11-21 | LEAM | N | N | 310014474 | LEAM |
| 310006947 | 310004148 | 1.61 | null | Curative (C) | null | 2015-09-27 | Brentuximab | N | N | 310014483 | BRENTUXIMAB |
| 310006948 | 310004150 | 1.61 | 142.8 | Palliative (P) | 2015-03-07 | 2015-03-25 | CARBOPLATIN + LIPOSOMAL DOX | 02 | N | 310014489 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006949 | 310004151 | 1.18 | 85.4 | Curative (C) | 2016-03-18 | 2016-03-31 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310014504 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006951 | 310004153 | null | 111 | Curative (C) | 2015-10-26 | 2015-11-05 | Brentuximab | N | N | 310014528 | BRENTUXIMAB |
| 310006953 | 310007726 | 1.65 | 66.2 | Palliative (P) | 2018-02-17 | 2018-03-07 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310014547 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006954 | 310007726 | 1.28 | 52.4 | null | 2017-02-20 | 2017-02-22 | Olaratumab | 02 | N | 310014547 | NOT MATCHED |
| 310006955 | 310004155 | 1.58 | 85 | Curative (C) | null | 2018-10-28 | BEAM | N | N | 310014558 | BEAM |
| 310006956 | 310004155 | null | 97.8 | Disease modification (D) | 2013-04-10 | 2013-04-24 | Brentuximab | 02 | null | 310014558 | BRENTUXIMAB |
| 310006957 | 310004155 | 1.63 | 102.5 | Curative (C) | 2016-06-22 | 2016-06-29 | LEAM | N | N | 310014558 | LEAM |
| 310006958 | 310004156 | 1.81 | 99.1 | Palliative (P) | 2013-05-26 | 2013-06-08 | Brentuximab | N | N | 310014574 | BRENTUXIMAB |
| 310006959 | 310004157 | 1.75 | 51 | Palliative (P) | 2016-10-29 | 2016-10-29 | PEMBROLIZUMAB | 02 | N | 310014582 | PEMBROLIZUMAB |
| 310006960 | 310004158 | 1.73 | 116.4 | Palliative (P) | 2017-07-09 | 2017-08-30 | PEMBROLIZUMAB | N | N | 310014582 | PEMBROLIZUMAB |
| 310006963 | 310009619 | 1.79 | null | Palliative (P) | 2015-03-13 | 2015-04-04 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310014597 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006964 | 310004160 | 1.6 | 53.2 | Palliative (P) | 2017-08-28 | 2017-08-28 | PEMBROLIZUMAB | 02 | N | 310014597 | PEMBROLIZUMAB |
| 310006965 | 310010632 | 1.75 | 49.1 | Curative (C) | 2014-10-19 | 2015-04-03 | BEAM | N | null | 310014635 | BEAM |
| 310006966 | 310004161 | 1.66 | 103 | Disease modification (D) | null | 2013-03-14 | CISPLATIN + GEMCITABINE | N | N | 310014640 | CISPLATIN + GEMCITABINE |
| 310006967 | 310009621 | 1.63 | 68.5 | Curative (C) | 2015-02-06 | 2015-05-03 | PEMBROLIZUMAB | N | N | 310014647 | PEMBROLIZUMAB |
| 310006968 | 310004162 | 1.74 | 58.7 | Curative (C) | 2017-04-02 | 2017-04-03 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | N | N | 310014659 | NOT MATCHED |
| 310006971 | 310004166 | 1.6 | 66.76 | Palliative (P) | 2017-04-21 | 2017-04-21 | Brentuximab Vedotin | 02 | null | 310014679 | BRENTUXIMAB |
| 310006972 | 310004166 | null | null | Palliative (P) | 2017-05-26 | 2017-06-09 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310014679 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006973 | 310009623 | null | 19 | Palliative (P) | 2017-11-11 | 2017-11-12 | Carboplatin + Liposomal Doxorubicin | N | N | 310014692 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006974 | 310009623 | 1.65 | 63 | Curative (C) | 2014-07-17 | 2014-07-19 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | null | 310014692 | CISPLATIN + GEMCITABINE |
| 310006975 | 310009623 | 1.69 | 76.55 | Palliative (P) | 2016-03-29 | 2016-03-29 | PEMBROLIZUMAB | 02 | N | 310014692 | PEMBROLIZUMAB |
| 310006976 | 310004167 | 1.77 | 72 | null | 2018-05-04 | 2018-05-10 | Gemcitabine day 1&8 | N | N | 310014723 | GEMCITABINE |
| 310006977 | 310004168 | 1.78 | 78.8 | Curative (C) | 2017-10-07 | 2018-02-05 | BEAM | N | N | 310014736 | BEAM |
| 310006978 | 310004169 | 1.72 | 76.1 | Curative (C) | 2014-01-29 | 2014-01-29 | Mini BEAM | 02 | N | 310014737 | BEAM |
| 310006979 | 310004170 | 1.6 | 74 | null | 2016-09-23 | 2016-09-23 | CISPLATIN + GEMCITABINE | N | N | 310014746 | CISPLATIN + GEMCITABINE |
| 310006980 | 310004170 | 1.73 | 62 | Curative (C) | 2017-03-01 | 2017-04-03 | GEMCITABINE | N | N | 310014746 | GEMCITABINE |
| 310006981 | 310004170 | null | 8 | Neo-adjuvant (N) | 2013-06-16 | 2016-06-29 | NB HRNBL-1 TVD | N | N | 310014746 | NOT MATCHED |
| 310006982 | 310004170 | 1.62 | 112.5 | Palliative (P) | 2013-11-02 | 2013-11-02 | Carboplatin + Liposomal Doxorubicin | N | N | 310014746 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006983 | 310007737 | 1.7 | 24.9 | Palliative (P) | 2017-05-28 | 2017-05-30 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310014785 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006984 | 310007737 | 1.64 | 54.7 | null | 2016-04-21 | 2016-04-21 | Brentuximab | 02 | N | 310014785 | BRENTUXIMAB |
| 310006985 | 310004172 | 1.66 | 121.9 | T | 2018-05-09 | 2018-05-09 | Mini BEAM | N | N | 310014814 | BEAM |
| 310006986 | 310004173 | 1.79 | 60.1 | Palliative (P) | 2016-01-25 | 2016-03-15 | CARBOPLATIN + LIPOSOMAL DOX | N | N | 310014826 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006987 | 310004173 | 1.55 | 77.2 | Curative (C) | 2016-01-22 | 2016-01-27 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310014826 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006989 | 310004176 | 1.66 | 82.5 | Curative (C) | 2017-03-21 | 2017-03-21 | BEAM | 2 | N | 310014851 | BEAM |
| 310006990 | 310004177 | 1.4 | 58.2 | Palliative (P) | 2017-04-03 | 2017-05-08 | PEMBROLIZUMAB | N | N | 310014855 | PEMBROLIZUMAB |
| 310006991 | 310004177 | 1.7 | 112 | Palliative (P) | 2014-04-07 | 2014-04-14 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310014855 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006992 | 310004177 | null | 111.3 | Curative (C) | 2017-08-12 | 2017-08-27 | Brentuximab | N | N | 310014855 | BRENTUXIMAB |